TY  - JOUR
T1  - CHild advocacy and robust community-centered research
AU  - Feudtner C
Y1  - 2001/04/01
N1  - 10.1001/archpedi.155.4.438
JO  - Archives of Pediatrics & Adolescent Medicine
SP  - 438
EP  - 439
VL  - 155
IS  - 4
N2  - 
DOES THE DRUG piracetam improve the cognition of children with Down syndrome?1 In contrast with exuberant testimonials appearing on television and the Internet, Lobaugh et al2 found no substantial benefit in their randomized controlled study. Despite the trial's relatively small cohort size, its rigorous double-blinded crossover design should earn our respect, while their findings (especially of undesirable behavioral effects) should temper our enthusiasm for piracetam markedly.

SN  - 1072-4710
M3  - doi: 10.1001/archpedi.155.4.438
UR  - http://dx.doi.org/10.1001/archpedi.155.4.438
ER  -